Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03598270
Title Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Cancer de Ovario

fallopian tube carcinoma

peritoneal carcinoma

endometrioid ovary carcinoma

ovarian serous carcinoma


Carboplatin + Gemcitabine


Carboplatin + Pegylated liposomal-doxorubicin

Atezolizumab + Carboplatin + Pegylated liposomal-doxorubicin

Atezolizumab + Carboplatin + Gemcitabine

Atezolizumab + Carboplatin + Paclitaxel

Carboplatin + Paclitaxel

Atezolizumab + Niraparib

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU | BEL

No variant requirements are available.